Form 8-K - Current report:
SEC Accession No. 0001140361-25-013625
Filing Date
2025-04-14
Accepted
2025-04-14 07:55:42
Documents
13
Period of Report
2025-04-14
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K ef20047328_8k.htm   iXBRL 8-K 27762
  Complete submission text file 0001140361-25-013625.txt   162857

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vcel-20250414.xsd EX-101.SCH 3973
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcel-20250414_lab.xml EX-101.LAB 21966
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcel-20250414_pre.xml EX-101.PRE 16038
15 EXTRACTED XBRL INSTANCE DOCUMENT ef20047328_8k_htm.xml XML 4044
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

EIN.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35280 | Film No.: 25834234
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)